Benefit–risk of intraoperative liver biopsy during bariatric surgery: review and perspectives
- 1 October 2017
- journal article
- review article
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 13 (10) , 1780-1786
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver DiseaseObesity Facts, 2016
- Nonalcoholic Fatty Liver Disease and Incident Cardiac EventsJACC, 2016
- Natural History of Nonalcoholic Fatty Liver DiseaseDigestive Diseases and Sciences, 2016
- Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisMayo Clinic Proceedings, 2015
- Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 DiabetesDiabetes Care, 2015
- Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitusWorld Journal of Gastroenterology, 2015
- Hepatic Pathology among Patients without Known Liver Disease Undergoing Bariatric Surgery: Observations and a Perspective from the Longitudinal Assessment of Bariatric Surgery (LABS) StudySeminars in Liver Disease, 2014
- Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical ResearchSeminars in Liver Disease, 2012
- Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008Clinical Gastroenterology and Hepatology, 2011
- Histopathology of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology, 2010